top of page

We develop (non-coding) RNA therapeutics for incurable diseases using genomics and bioinformatics.

PI: Rory Johnson

Our mission is to develop better therapies for common diseases through understanding the original molecule of Life: RNA.

We develop tools based on CRISPR-Cas genome-editing and bioinformatics to discover and drug disease-causing RNAs.


We focus on the important yet mysterious class of long noncoding RNAs (lncRNAs).

We are an interdisciplinary, international research group based at University College Dublin.

 Latest News

bottom of page